Stocks
Liquidia CorporationLQDA
NASDAQHealthcareBiotechnology$36.41
A biotechnology company developing inhaled therapeutics using its proprietary PRINT particle engineering platform to control drug particle size and delivery. Its lead program, Yutrepia (inhaled treprostinil), targets pulmonary arterial hypertension and pulmonary hypertension associated with intersti...
52W Range: $11.26 – $46.67
Congressional Interest in Liquidia Corporation (LQDA)
1 member of Congress has disclosed 1 trade in Liquidia Corporation (LQDA), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading LQDA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-11-25 | Jared Polis | sell | $100K – $250K |